These GLP-1 weight loss medications aid countless patients in achieving sustainable weight loss
In earlier Phase 2 data, people taking retatrutide for six months lost up to 17.5% of their body weight at 24 weeks
Reasonable approaches include: Regular blood work every 3-6 months checking metabolic markers, liver function, kidney function, and lipid profiles
Appetite hormones such as ghrelin, GLP-1, and PYY may shift back toward preoperative patterns
ChaC1 has three isoforms: Isoform A, Isoform B, and Isoform X1, which vary in their structure and functionality
Exercise for sarcopenia in older people: a systematic review and network meta-analysis